Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse?

被引:132
作者
Sidhu, A
Wersinger, C
Vernier, P
机构
[1] Georgetown Univ, Dept Pediat, Washington, DC USA
[2] CNRS, Inst Neurobiol Alfred FESSARD, F-91198 Gif Sur Yvette, France
关键词
dopamine transporter; Parkinson's disease; synucleopathies; neurodegeneration; MPTP; Lewy bodies;
D O I
10.1096/fj.03-1112rev
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-Synuclein is a key component of the pathological process of neurodegeneration in Parkinson's disease. Although its contributions to normal physiological conditions remain elusive, converging observations suggest that a primary function of this protein in dopaminergic neurons may be the regulation of dopamine content and synaptic tone at the synapse. We review here cumulative evidence that demonstrates the participation of alpha-synuclein in the life cycle of dopamine from its synthesis, storage, release, and reuptake. The regulatory role of alpha-synuclein on dopamine metabolism is assessed by discussing the experimental evidence supporting each of these observations in the healthy physiological maintenance of dopaminergic neurons, as well as showing how disruption of these events can initiate the observed neurotoxicity of alpha-synuclein and the genesis of the degenerative processes associated with Parkinson's disease.
引用
收藏
页码:637 / 647
页数:11
相关论文
共 148 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   A-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells [J].
Ahn, BH ;
Rhim, H ;
Kim, SY ;
Sung, YM ;
Lee, MY ;
Choi, JY ;
Wolozin, B ;
Chang, JS ;
Lee, YH ;
Kwon, TK ;
Chung, KC ;
Yoon, SH ;
Hahn, SJ ;
Kim, MS ;
Jo, YH ;
Min, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12334-12342
[3]   Tubulin seeds α-synuclein fibril formation [J].
Alim, MA ;
Hossain, MS ;
Arima, K ;
Takeda, K ;
Izumiyama, Y ;
Nakamura, M ;
Kaji, H ;
Shinoda, T ;
Hisanaga, S ;
Uéda, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :2112-2117
[4]  
Baba M, 1998, AM J PATHOL, V152, P879
[5]   Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity [J].
Bodles, AM ;
Guthrie, DJS ;
Greer, B ;
Irvine, GB .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :384-395
[6]  
Cabin DE, 2002, J NEUROSCI, V22, P8797
[7]   Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease [J].
Chan, P ;
Jiang, X ;
Forno, LS ;
Di Monte, DA ;
Tanner, CM ;
Langston, JW .
NEUROLOGY, 1998, 50 (04) :1136-1137
[8]   A broken α-helix in folded α-synuclein [J].
Chandra, S ;
Chen, XC ;
Rizo, J ;
Jahn, R ;
Südhof, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) :15313-15318
[9]   Structure and function of the dopamine transporter [J].
Chen, NH ;
Reith, MEA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 405 (1-3) :329-339
[10]  
Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO